Olmutinib in T790M‐positive non–small cell lung cancer after failure of first‐line epidermal growth factor receptor‐tyrosine kinase inhibitor therapy: A global, phase 2 study
Journal article published in 2021 by
Keunchil Park 
,
Pasi A. Jӓnne,
Dong‐Wan Kim,
Ji‐Youn Han,
Ming‐Fang Wu,
Jong‐Seok Lee,
Jin‐Hyoung Kang,
Dae Ho Lee,
Byoung Chul Cho ,
Chong‐Jen Yu ,
Yong Kek Pang,
Enriqueta Felip,
Hyunjin Kim,
Eunhye Baek,
Young Su Noh
,
Pasi A. Jӓnne,
Dong‐Wan Kim,
Ji‐Youn Han,
Ming‐Fang Wu,
Jong‐Seok Lee,
Jin‐Hyoung Kang,
Dae Ho Lee,
Byoung Chul Cho ,
Chong‐Jen Yu ,
Yong Kek Pang,
Enriqueta Felip,
Hyunjin Kim,
Eunhye Baek,
Young Su Noh
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 